|Bid||0.890 x 0|
|Ask||0.930 x 0|
|Day's Range||0.920 - 0.930|
|52 Week Range||0.740 - 1.800|
|Beta (3Y Monthly)||0.35|
|PE Ratio (TTM)||9.46|
|Forward Dividend & Yield||0.03 (3.65%)|
|1y Target Est||1.81|
If you want to know who really controls Kingworld Medicines Group Limited (HKG:1110), then you’ll have to look at the makeup of its share registry. Insiders often own a large Read More...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
I am writing today to help inform people who are new to the stock market and want to begin learning about how to value company based on its current earningsRead More...
A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. In the past 7 years Kingworld Medicines Group Limited (HKG:1110)Read More...
March 29 (Reuters) - Kingworld Medicines Group Ltd : * FY REVENUE DECREASED BY 2.1% TO RMB1.03 BILLION * FY PROFIT ATTRIBUTABLE INCREASED 8.7% TO ABOUT RMB51.1 MILLION * BOARD RECOMMENDED DISTRIBUTION ...
Shares of Hong Kong-listed pharmaceutical distributor Kingworld Medicines Group Ltd. soared as much as 55% Monday after a Wall Street Journal article about growing use of its signature product in the U.S. ...
Shares in Kingworld Medicines Group popped Monday following a U.S. news report that New Yorkers were snapping up a cough syrup it sold.